Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
107.95
-2.74 (-2.48%)
At close: Aug 6, 2026, 4:00 PM EDT
107.99
+0.04 (0.04%)
Pre-market: Aug 7, 2026, 7:56 AM EDT
Corcept Therapeutics Market Cap
Corcept Therapeutics has a market cap or net worth of $11.67 billion as of August 7, 2026. Its market cap has increased by 57.20% in one year.
Market Cap
11.67B
Enterprise Value
11.13B
1-Year Change
57.20%
Ranking
Category
Stock Price
$107.95
ChartMarket Cap Chart
Since April 14, 2004, Corcept Therapeutics's market cap has increased from $283.00M to $11.67B, an increase of 4,023.40%. That is a compound annual growth rate of 18.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 11.67B | 218.79% |
| Dec 31, 2025 | 3.66B | -30.67% |
| Dec 31, 2024 | 5.28B | 57.69% |
| Dec 29, 2023 | 3.35B | 53.13% |
| Dec 30, 2022 | 2.19B | -4.35% |
| Dec 31, 2021 | 2.29B | -24.78% |
| Dec 31, 2020 | 3.04B | 119.78% |
| Dec 31, 2019 | 1.38B | -10.36% |
| Dec 31, 2018 | 1.54B | -25.15% |
| Dec 29, 2017 | 2.06B | 155.69% |
| Dec 30, 2016 | 806.10M | 48.81% |
| Dec 31, 2015 | 541.70M | 78.43% |
| Dec 31, 2014 | 303.60M | -5.24% |
| Dec 31, 2013 | 320.40M | 124.53% |
| Dec 31, 2012 | 142.70M | -50.47% |
| Dec 30, 2011 | 288.10M | 3.11% |
| Dec 31, 2010 | 279.40M | 60.85% |
| Dec 31, 2009 | 173.70M | 248.10% |
| Dec 31, 2008 | 49.90M | -59.17% |
| Dec 31, 2007 | 122.20M | 336.43% |
| Dec 29, 2006 | 28.00M | -66.22% |
| Dec 30, 2005 | 82.90M | -41.54% |
| Dec 31, 2004 | 141.80M | -49.89% |
| Apr 14, 2004 | 283.00M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Exelixis | 14.25B |
| Arrowhead Pharmaceuticals | 12.28B |
| Madrigal Pharmaceuticals | 11.88B |
| BioMarin Pharmaceutical | 11.58B |
| Bio-Techne | 11.22B |
| Axsome Therapeutics | 10.95B |
| Summit Therapeutics | 10.79B |
| ABIVAX Société Anonyme | 10.79B |